Mylan, the creator of the EpiPen, tying executive pay to high profit margins has increased the price 6 fold in 8 years. What can we do to solve this non competitive state of the drug market?
Mylan, the creator of the EpiPen, tying executive pay to high profit margins has increased the price 6 fold in 8 years. What can we do to solve this non competitive state of the drug market?